ICD-10-PCS Code Range for Determining the level of a physiological or physical function at a point in time
ICD-10-PCS Code Range for Determining the level of a physiological or physical function at a point in time is medical classification list by Centers for Medicare and Medicaid Services (CMS).
ICD-10-PCS code range (XXE), contains ICD-10-PCS codes for Nervous System, New Technology, Physiological Systems, Determining the level of a physiological or physical function at a point in time.
PCS Tables
| X New Technology |
| X Physiological Systems |
| E Measurement: Determining the level of a physiological or physical function at a point in time |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|---|---|---|---|
| Character 4 | Character 5 | Character 6 | Character 7 |
Body System (Character 4)
0 Central Nervous | Approach (Character 5) X External | Substance (Character 6) 0 Intracranial Vascular Activity, Computer-aided Assessment | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
0 Central Nervous | Approach (Character 5) X External | Substance (Character 6) 1 Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification | Qualifier (Character 7) A New Technology Group 10 | Body System (Character 4)
0 Central Nervous | Approach (Character 5) X External | Substance (Character 6) 4 Brain Electrical Activity, Computer-aided Semiologic Analysis | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
2 Cardiac | Approach (Character 5) X External | Substance (Character 6) 1 Output, Computer-aided Assessment | Qualifier (Character 7) 9 New Technology Group 9 | Body System (Character 4)
3 Arterial | Approach (Character 5) X External | Substance (Character 6) 2 Pulmonary Artery Flow, Computer-aided Triage and Notification | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
3 Arterial | Approach (Character 5) X External | Substance (Character 6) 5 Coronary Artery Flow, Quantitative Flow Ratio Analysis6 Coronary Artery Flow, Computer-aided Valve Modeling and Notification | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) 2 Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum | Qualifier (Character 7) A New Technology Group 10 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) 3 Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) 4 Infection, Positive Blood Culture Small Molecule Sensor Array Technology | Qualifier (Character 7) A New Technology Group 10 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) N Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility | Qualifier (Character 7) 6 New Technology Group 6 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) R Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative PressureT Intracranial Arterial Flow, Whole Blood mRNA V Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) Y Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology | Qualifier (Character 7) 9 New Technology Group 9 | Body System (Character 4)
9 Nose | Approach (Character 5) 7 Via Natural or Artificial Opening | Substance (Character 6) U Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
B Respiratory | Approach (Character 5) X External | Substance (Character 6) Q Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection | Qualifier (Character 7) 6 New Technology Group 6 |
January 01, 1970
Novitas and FCSO will require documentation for certain pathology and laboratory claims. Medicare Administrative Contractors MAC Novitas Solutions and First Coast Service Options FCSO recently announc... [ Read More ]
January 01, 1970
Potential erroneous Medicare payments million to treat patients with opioid use disorder OUD are estimated at 17.8 million. The opioid crisis in the United States has led to record numbers of people d... [ Read More ]
January 01, 1970
Get an overview of key updates to the postacute care quality reporting programs for 2025. The Centers for Medicare 38 Medicaid Services is offering a crosssetting webbased training course that provide... [ Read More ]
January 01, 1970
Hospitals should use this tool to protect their profit margins. Diagnosisrelated group DRG validation ensures the accuracy of DRG assignment and payment for inpatient hospital stays. Since inpatient c... [ Read More ]
January 01, 1970
Meet a member who has made an indelible impression in the healthcare industry. AAPCs Member of the Month Nancy Reading RN BS CPC CPCP CPCI is a longtime member and a pillar in the healthcare community... [ Read More ]
... [ Read More ]